Novartis AG
NVS | NYSE
$141.31
+$0.33 (+0.23%)
Sep 22, 2026, 2:09 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 11.44B | 11.46B | 13.39B | 7.52B | 12.41B | 9.66B |
Short-Term Investments | 155M | 1.89B | 569M | 11.1B | 15.71B | 1.91B |
Long-Term Investments | 2.3B | 1.13B | 1.83B | 1.61B | 2.27B | 12.44B |
Other Long-Term Assets | 5.42B | 4.51B | 2.18B | 2.06B | 3.18B | 981M |
Receivables | 10.93B | 8.21B | 9.38B | 9.89B | 9.62B | 9.07B |
Inventory | 6.27B | 5.72B | 5.91B | 7.18B | 6.67B | 7.13B |
Other Current Assets | 514M | 1.43B | 466M | 315M | 216M | 963M |
Total Current Assets | 30.46B | 29.7B | 30.48B | 36.91B | 45.72B | 29.67B |
Property-Plant & Equipment | 12.35B | 10.87B | 10.92B | 12.2B | 13.11B | 13.94B |
Goodwill & Intangibles | 54.98B | 51.67B | 50.22B | 60.95B | 63.78B | 66.81B |
Total Long-Term Assets | 85.11B | 72.54B | 69.46B | 80.54B | 86.08B | 102.52B |
Total Assets | 115.57B | 102.25B | 99.95B | 117.45B | 131.8B | 132.19B |
Account Payables | 4.46B | 4.57B | 4.93B | 5.15B | 5.55B | 5.4B |
Deferred Revenue | n/a | 127M | 98M | 123M | 123M | 56M |
Short-Term Debt | 5.78B | 8.09B | 6.08B | 5.88B | 6.23B | 9.88B |
Other Current Liabilities | 12.82B | 10.38B | 9.84B | 11.21B | 12.44B | 12.98B |
Total Current Liabilities | 27.28B | 28.69B | 26.39B | 28.66B | 30.21B | 33.06B |
Long-Term Debt | 29.59B | 21.37B | 18.44B | 20.24B | 22.9B | 26.26B |
Other Long-Term Liabilities | 2.48B | 4.08B | 4.52B | 4.91B | 6.17B | 6.93B |
Total Long-Term Liabilities | 41.74B | 29.43B | 26.81B | 29.37B | 33.77B | 42.46B |
Total Liabilities | 69.02B | 58.12B | 53.2B | 58.03B | 63.97B | 75.52B |
Total Debt | 37.03B | 31.26B | 26.35B | 27.91B | 31.03B | 37.86B |
Book Value | 46.55B | 44.13B | 46.75B | 59.42B | 67.82B | 56.67B |
Book Value Per Share | 23.81 | 21.68 | 22.35 | 27.05 | 30.01 | 24.68 |
Common Stock | 766M | 793M | 825M | 890M | 901M | 913M |
Retained Earnings | 44.72B | 46.56B | 49.65B | 63.54B | 70.99B | 57.16B |
Comprehensive Income | 694M | -3.26B | -3.77B | -5B | -4.19B | -1.42B |
Shareholders Equity | 46.13B | 44.05B | 46.67B | 59.34B | 67.66B | 56.6B |
Total Investments | 2.46B | 3.02B | 2.4B | 12.7B | 17.97B | 14.35B |
Add to Watchlist
Select watchlists to add or remove NVS